D.Western Therapeutics Institute, Inc. (4576)

Market cap
¥4.9B
P/E ratio
-6.2x
De Western Therapeutics Institute develops protein kinase inhibitor drugs for eye diseases and licenses them to pharmaceutical companies for commercialization.
Period EndRevenue growth (%) YoY (%)
Dec 31, 2025-17.8-276.41%
Dec 31, 202410.1-329.32%
Dec 31, 2023-4.4-154.12%
Dec 31, 20228.1-50.88%
Dec 31, 202116.6-142.71%
Dec 31, 2020-38.7-139.47%
Dec 31, 201998.2+541.28%
Dec 31, 201815.3-70.10%
Dec 31, 201751.2-70.19%
Dec 31, 2016171.8-855.03%
Dec 31, 2015-22.7-75933.33%
Dec 31, 20140-100.10%
Dec 31, 2013-28.9-106.25%
Dec 31, 2012462.5
AI Chat